BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31126596)

  • 1. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
    Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
    J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
    Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
    Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
    Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
    HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation Zone Involution of Liver Tumors Is Faster in Patients Treated with Irreversible Electroporation Than Microwave Ablation.
    Ridouani F; Ghosn M; Cornelis F; Petre EN; Hsu M; Moskowitz CS; Kingham PT; Solomon SB; Srimathveeravalli G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577800
    [No Abstract]   [Full Text] [Related]  

  • 6. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
    Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
    Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
    Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
    Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible electroporation induces CD8
    Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
    Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
    Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
    Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological effect of irreversible electroporation on hepatocellular carcinoma.
    Guo X; Du F; Liu Q; Guo Y; Wang Q; Huang W; Wang Z; Ding X; Wu Z
    BMC Cancer; 2021 Apr; 21(1):443. PubMed ID: 33882892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
    Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors.
    Verloh N; Jensch I; Lürken L; Haimerl M; Dollinger M; Renner P; Wiggermann P; Werner JM; Zeman F; Stroszczynski C; Beyer LP
    Radiol Oncol; 2019 Mar; 53(1):116-122. PubMed ID: 30840591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous irreversible electroporation of hepatocellular carcinoma: Contrast-enhanced ultrasound-findings during 1-year follow-up.
    Niessen C; Beyer LP; Haimerl M; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 72(1):85-93. PubMed ID: 30584122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local ablation for hepatocellular carcinoma.
    Boyvat F
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():55-9. PubMed ID: 24635794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
    Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.